David Fernández‐López

Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection

Juan G. Zarruk, David Fernández‐López, Isaac García‐Yébenes et al. · Stroke · 2011 · 220 citations

Medicine, Neuroscience, Pharmacology +17

Blood-Brain Barrier Permeability Is Increased After Acute Adult Stroke But Not Neonatal Stroke in the Rat

David Fernández‐López, Joel Faustino, Richard Daneman et al. · Journal of Neuroscience · 2012 · 216 citations · Full text

Medicine, Neurobiology, Neuroscience +17

Synthesis of Lipoxin A₄by 5-Lipoxygenase Mediates PPARγ-Dependent, Neuroprotective Effects of Rosiglitazone in Experimental Stroke

Mónica Sobrado, Marta P. Pereira, Iván Ballesteros et al. · Journal of Neuroscience · 2009 · 124 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Toll‐like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning

Jesús M. Pradillo, David Fernández‐López, Isaac García‐Yébenes et al. · Journal of Neurochemistry · 2009 · 123 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Characterization of the Neuroprotective Effect of the Cannabinoid Agonist WIN-55212 in an In Vitro Model of Hypoxic-Ischemic Brain Damage in Newborn Rats

David Fernández‐López, José Martínez‐Orgado, Estefanía Núñez et al. · Pediatric Research · 2006 · 104 citations

Medicine, Neuroscience, Pharmacology +12